Evogene (EVGN)
(Delayed Data from NSDQ)
$0.64 USD
-0.04 (-6.45%)
Updated Apr 18, 2024 03:59 PM ET
After-Market: $0.64 0.00 (-0.12%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/16/2024
Time: -- |
3/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, Evogene (EVGN) reported earnings of -$0.13 per share, beating the Zacks Consensus Estimate of $-0.14 per share. This reflects a positive earnings surprise of 7.14%. Look out for EVGN's next earnings release expected on May 16, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 53.33%.
Earnings History
Price & Consensus
Zacks News for EVGN
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
EVGN: What are Zacks experts saying now?
Zacks Private Portfolio Services